Page last updated: 2024-08-23

sufentanil and sb 216763

sufentanil has been researched along with sb 216763 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, YY; Chen, QL; Fang, WP; Gu, EW; Zhang, L; Zhu, Y	1

Other Studies

1 other study(ies) available for sufentanil and sb 216763

Article	Year
Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β. Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:2 Topics: Anesthetics, Intravenous; Animals; Blood Pressure; Blotting, Western; Cardiotonic Agents; Diabetes Mellitus, Experimental; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Heart Rate; Indoles; Male; Maleimides; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sufentanil; Troponin I	2013

Article

Year

Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β.

Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:2

Topics: Anesthetics, Intravenous; Animals; Blood Pressure; Blotting, Western; Cardiotonic Agents; Diabetes Mellitus, Experimental; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Heart Rate; Indoles; Male; Maleimides; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sufentanil; Troponin I

2013